Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Artigo em Alemão | MEDLINE | ID: mdl-26235357

RESUMO

Ostrich farming and keeping in Germany is of increasing interest. Ostrich farming includes keeping the animals as agricultural livestock (production of meat, leather, eggs), for display, hobby farming and keeping in zoological collections. Based on scientific research there is a steady increase in knowledge of keeping ratites according to sophisticated standards in terms of animal welfare legislation. Legislation and recommondations for keeping of ratitae are described.


Assuntos
Criação de Animais Domésticos/educação , Criação de Animais Domésticos/legislação & jurisprudência , Bem-Estar do Animal/legislação & jurisprudência , Paleógnatas , Animais , Alemanha
2.
Dermatology ; 196(3): 330-4, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9621141

RESUMO

BACKGROUND: Pilot studies of adjuvant therapy with topically applied interferons (IFN) have shown promising results in reducing the recurrence of condylomata acuminata (CA). OBJECTIVE: The aim of this multicenter placebo-controlled, double-blind study was to confirm the efficacy and safety of topically applied IFN in a large sample of patients. METHODS: After removal of CA by CO2 laser surgery, electrocautery or cryosurgery, 120 patients applied either recombinant IFN-beta (0.15 or 1.0 x 10(6) IU/g) or placebo gel to the affected areas 5 times daily for 4 weeks. The patients were followed for a total of 24 weeks or until recurrence of CA was observed, respectively. RESULTS: In the 105 patients evaluated for efficacy after 24 weeks, recurrence rates were 75% (27/36 patients) in the placebo group, 62% (21/34) in the 1.0 x 10(6) IU/g group (n.s.) and 54% (19/35) in the 0.15 x 10(6) IU/g group (p = 0.034). Only few mild adverse events were noted, which were almost limited to the application site. CONCLUSION: Topical application of gel containing 0.15 x 10(6) IU/g recombinant IFN-beta is safe and appears to reduce the recurrence of CA after surgical treatment.


Assuntos
Antivirais/uso terapêutico , Condiloma Acuminado/tratamento farmacológico , Interferon beta/uso terapêutico , Dermatopatias/tratamento farmacológico , Administração Cutânea , Adulto , Quimioterapia Adjuvante , Condiloma Acuminado/prevenção & controle , Método Duplo-Cego , Feminino , Humanos , Masculino , Projetos Piloto , Proteínas Recombinantes/uso terapêutico , Recidiva , Dermatopatias/prevenção & controle , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...